Volume 20 Issue 2
Feb.  2022
Turn off MathJax
Article Contents
Article Navigation >  Chinese Journal of General Practice  > 2022  >  20(2): 307-310
ZHANG Kui-ming, CUI Ying-lin, GE Luan-die, HOU Lu-yang, MA Rui-hong. Mechanism of Kangyi capsule in the treatment of ischaemic stroke based on 'pathology-prescription syndrome'[J]. Chinese Journal of General Practice, 2022, 20(2): 307-310. doi: 10.16766/j.cnki.issn.1674-4152.002339
Citation: ZHANG Kui-ming, CUI Ying-lin, GE Luan-die, HOU Lu-yang, MA Rui-hong. Mechanism of Kangyi capsule in the treatment of ischaemic stroke based on "pathology-prescription syndrome"[J]. Chinese Journal of General Practice, 2022, 20(2): 307-310. doi: 10.16766/j.cnki.issn.1674-4152.002339
shu

Mechanism of Kangyi capsule in the treatment of ischaemic stroke based on "pathology-prescription syndrome"

doi: 10.16766/j.cnki.issn.1674-4152.002339
  • 1.

    The Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, Henan 450002, China

Funds:

 81573911

 2019ZY2003

 2017ZY1020

 212102311123

  • Received Date: 2021-03-08
    Available Online: 2022-03-04
    Abstract
  • Ischaemic stroke, also known as cerebral infarction, is a heterogeneous neurological disease induced by sudden onset and multi-environmental risk factors and is accompanied by symptoms of neurological impairment. In recent years, the renewal of antiembolic drugs and the improvement in interventional therapy have greatly enhanced the therapeutic effect of ischaemic stroke and improved the quality of life of patients. However, the limitation of the thrombolytic window period and the specificity of interventional therapy seriously restrict its benefits. Moreover, the 5-year recurrence rate and mortality rate of the disease remain high. With the characteristics of multi-component, multi-link, multi-target, and overall treatment, traditional Chinese medicine is simple and low cost. It is effective in the clinical treatment of ischaemic stroke. Therefore, from the perspective of pathology to explore the molecular biological mechanism of ischaemic stroke, theoretical studies on the commonness of cerebral ischaemic disease, combined with modern research on prescription and syndrome pharmacology, are effective ways to explore the disease. Kangyi capsule is a hospital preparation formulated by experts in the Henan Hospital of Traditional Chinese Medicine on the basis of predecessors and according to the aetiology and pathogenesis of ischaemic stroke. It has the effect of replenishing qi and activating blood circulation, removing blood stasis, and dredging collaterals. It has unique advantages in the treatment of ischaemic stroke with complex pathology. Modern pharmacological studies have proven that Kangyi capsule can improve the nerve injury of ischaemic and hypoxic cerebrovascular diseases. Drugs in the prescription can improve the energy metabolism of ischaemic nerve cells, eliminate oxygen free radicals, inhibit inflammatory cascade reaction, relieve intracellular calcium overload, block the process of apoptosis, protect the damaged blood-brain barrier, reduce blood lipids, inhibit platelet aggregation, promote thrombolysis, and play an anti-embolism role. The author summarises the modern pathophysiological mechanism of ischaemic stroke, the theoretical understanding of traditional Chinese medicine, and the prescription and syndrome study of Kangyi capsule to provide a basis for the theoretical research and clinical application of Kangyi capsule.

     

    • FullText(HTML)
  • loading
    • References(36)
  • [1]
    LEE R, LEE M, WU C, et al. Cerebral ischemia and neuroregeneration[J]. Neural Regen Res, 2018, 13(3): 373-385. doi: 10.4103/1673-5374.228711
    [2]
    王陇德, 刘建民, 杨弋, 等. 我国脑卒中防治仍面临巨大挑战: 《中国脑卒中防治报告2018》概要[J]. 中国循环杂志, 2019, 34(2): 105-119. doi: 10.3969/j.issn.1000-3614.2019.02.001
    [3]
    FENG Z, SUN Q, CHEN W, et al. The neuroprotective mechanisms of ginkgolides and bilobalide in cerebral ischemic injury: A literature review[J]. Mol Med, 2019, 25(1): 57. doi: 10.1186/s10020-019-0125-y
    [4]
    SEKERDAG E, SOLAROGLU I, GURSOY-OZDEMIR Y. Cell death mechanisms in stroke and novel molecular and cellular treatment options[J]. Curr Neuropharmacol, 2018, 16(9): 1396-1415. doi: 10.2174/1570159X16666180302115544
    [5]
    DOMENICO M C, LUCA N R, MARIO D, et al. Neuroinflammatory mechanisms in ischemic stroke: Focus on cardioembolic stroke, background, and therapeuticapproaches[J]. Int J Mol Sci, 2020, 21(18): 6454. doi: 10.3390/ijms21186454
    [6]
    XU H, WANG E, CHEN F, et al. Neuroprotective phytochemicals in experimentalischemic stroke: Mechanisms and potential clinical applications[J]. Oxid Med Cell Longev, 2021, 2021(4): 1-45. http://www.researchgate.net/publication/351216238_Neuroprotective_Phytochemicals_in_Experimental_Ischemic_Stroke_Mechanisms_and_Potential_Clinical_Applications
    [7]
    SHIN T H, DA Y L, BASITH S, et al. Metabolome changes in cerebral Ischemia[J]. Cells, 2020, 9(7): 1630. doi: 10.3390/cells9071630
    [8]
    ZHAO M X, TUO H Z, WANG S H, et al. The roles of monocyte and monocyte-derived macrophages in common brain disorders[J]. Biomed Res Int, 2020. DOI: 10.1155/2020/9396021.
    [9]
    常成成, 魏聪. 从脉络学说角度探讨通络治疗脉络-血管系统病规律[J]. 中国中医基础医学杂志, 2019, 25(4): 487-489. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJC201904024.htm
    [10]
    孙凡, 刘恒, 付慧霄, 等. 急性脑梗死后出血转化的危险因素[J]. 中国老年学杂志, 2019, 39(17): 4163-4165. doi: 10.3969/j.issn.1005-9202.2019.17.017
    [11]
    崔占军, 刘芳, 赵凯冰, 等. APPSWE Tg2576小鼠脑屏障结构[J]. 解剖学报, 2018, 49(5): 571-578. https://www.cnki.com.cn/Article/CJFDTOTAL-JPXB201805002.htm
    [12]
    周韩, 周德生, 刘利娟, 等. 缺血中风荣气虚滞病机源流[J]. 中医学报, 2019, 34(9): 1844-1849. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZK201909010.htm
    [13]
    杨仁义, 周德生, 傅馨莹, 等. 基于"荣气理论-促血管新生"探讨脑梗死的防治策略[J]. 湖南中医药大学学报, 2020, 40(12): 1562-1566. doi: 10.3969/j.issn.1674-070X.2020.12.024
    [14]
    梁晓静, 淳于宣璐, 钟悦, 等. 袁青基于"脑-肠轴"理论应用靳三针治疗失神经验[J]. 广州中医药大学学报, 2021, 38(7): 1495-1500. https://www.cnki.com.cn/Article/CJFDTOTAL-REST202107034.htm
    [15]
    韩娟, 荣培晶, 王宏才, 等. 基于脑肠互动学说探析针刺治疗功能性消化不良[J]. 中医杂志, 2021, 62(10): 845-849. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202110005.htm
    [16]
    付跃峰, 张宇, 朱玉涵, 等. 通腑法论治中风病急性期[J]. 世界中医药, 2020, 15(10): 1498-1500. doi: 10.3969/j.issn.1673-7202.2020.10.028
    [17]
    章莹, 余建玮, 王飞. 基于《黄帝内经》理论谈国医大师伍炳彩辨治痿证经验[J]. 中华中医药杂志, 2020, 35(10): 4996-4998. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202010063.htm
    [18]
    刘寒, 张欢欢, 侯建平, 等. 基于"脑肠相通"理论的脑缺血与肠道菌群的关系探讨[J]. 中药药理与临床, 2017, 33(6): 173-176. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYL201706048.htm
    [19]
    李梦莘, 杜小正, 郑欣, 等. 基于"脑肠相通"探讨通下法治疗缺血性卒中机理[J]. 中国中医药信息杂志, 2020, 27(11): 17-19. https://www.cnki.com.cn/Article/CJFDTOTAL-XXYY202011004.htm
    [20]
    薛冰洁, 黄吉生, 马博, 等. 益气通络颗粒促气虚血瘀证脑梗大鼠血管新生的作用研究[J]. 中国中药杂志, 2019, 44(1): 112-118. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY201901017.htm
    [21]
    李贵明, 李燕. 人参皂苷药理作用研究现状[J]. 中国临床药理学杂志, 2020, 36(8): 1024-1027. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ202008024.htm
    [22]
    樊伟旭, 詹志来, 侯芳洁, 等. 红参的化学成分及药理作用研究进展[J]. 天然产物研究与开发, 2021, 33(1): 137-149. https://www.cnki.com.cn/Article/CJFDTOTAL-TRCW202101020.htm
    [23]
    HUANG X, LI N, PU Y Q, et al. Neuroprotective effects of ginseng phytochemicals: Recent perspectives[J]. Molecules, 2019, 24(16): 2939. doi: 10.3390/molecules24162939
    [24]
    杨帆, 戚莹雪, 张永清. 丹参地上部分化学成分与药理作用研究进展[J]. 中成药, 2020, 42(6): 1558-1564. doi: 10.3969/j.issn.1001-1528.2020.06.032
    [25]
    丁凡, 王拥军, 张岩. 丹参活性成分的药理作用和临床应用研究进展[J]. 中华中医药杂志, 2021, 36(2): 659-662. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202102009.htm
    [26]
    万新焕, 王瑜亮, 周长征, 等. 丹参化学成分及其药理作用研究进展[J]. 中草药, 2020, 51(3): 788-798. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO202003032.htm
    [27]
    邢娜, 彭东辉, 张志宏, 等. 炮制对三七化学成分及药理作用影响的研究进展[J]. 中国实验方剂学杂志, 2020, 26(16): 210-217. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202016030.htm
    [28]
    林晨, 陈闯. 三七总皂苷对创伤性脑损伤大鼠神经元凋亡的保护作用[J]. 中华全科医学, 2021, 19(6): 932-935. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202106013.htm
    [29]
    徐明杰, 赵迪, 李龙宇, 等. 水蛭素的药理作用及临床应用研究进展[J]. 中国现代中药, 2021, 23(4): 747-754. https://www.cnki.com.cn/Article/CJFDTOTAL-YJXX202104028.htm
    [30]
    CHENG R M, TANG X P, LONG A L, et al. Purification and characterization of a novel anti-coagulant from the leech Hirudinaria manillensis[J]. Zool Res, 2019, 40(3): 205-210. doi: 10.24272/j.issn.2095-8137.2019.037
    [31]
    王金贺, 王托资, 姜德友. 姜德友运用虫类药治疗心脑血管疾病经验[J]. 中华中医药杂志, 2020, 35(8): 3962-3965. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202008043.htm
    [32]
    王少平, 赵一慕, 李盼盼, 等. 基于网络药理学的土鳖虫破血逐瘀作用机制研究[J]. 中国现代中药, 2021, 23(3): 457-463. https://www.cnki.com.cn/Article/CJFDTOTAL-YJXX202103012.htm
    [33]
    李东辉, 王临艳, 吴红伟, 等. 大黄酚药理作用研究进展[J]. 中华中医药学刊, 2021, 39(12): 66-69. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJKB202006006.htm
    [34]
    李东辉, 王临艳, 吴红伟, 等. 大黄素药理作用研究新进展[J]. 中华中医药学刊, 2021, 39(9): 100-104. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS202109026.htm
    [35]
    王宝祥, 许俊杰, 陆霞, 等. SHH信号通路对大脑中动脉梗死模型大鼠脑缺血后的保护作用[J]. 中华全科医学, 2020, 18(7): 1112-1114. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202007014.htm
    [36]
    龙宇, 张羽璐, 万金艳, 等. 中药治疗缺血性脑卒中致多器官损伤的研究进展[J]. 中草药, 2021, 52(7): 2106-2116. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO202107028.htm
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (288) PDF downloads(5) Cited by()
    Proportional views
    Related

    Address：No. 287, Changhuai Road, Bengbu, Anhui Province, 233004, P.R.ChinaphoneNo：0552-3066635； 0552-3051890Email：zhqkyx@163.com

    Copyright © Chinese Journal of General Practice皖ICP备2020018345号-2

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return